Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Cited In for PubMed (Select 20956308)


Striatal-enriched protein tyrosine phosphatase controls responses to aversive stimuli: implication for ethanol drinking.

Legastelois R, Darcq E, Wegner SA, Lombroso PJ, Ron D.

PLoS One. 2015 May 20;10(5):e0127408. doi: 10.1371/journal.pone.0127408. eCollection 2015.


Fragile X mental retardation protein: from autism to neurodegenerative disease.

Wang H.

Front Cell Neurosci. 2015 Feb 12;9:43. doi: 10.3389/fncel.2015.00043. eCollection 2015. No abstract available.


Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice.

Dubal DB, Zhu L, Sanchez PE, Worden K, Broestl L, Johnson E, Ho K, Yu GQ, Kim D, Betourne A, Kuro-O M, Masliah E, Abraham CR, Mucke L.

J Neurosci. 2015 Feb 11;35(6):2358-71. doi: 10.1523/JNEUROSCI.5791-12.2015.


Synthesis of benzopentathiepin analogs and their evaluation as inhibitors of the phosphatase STEP.

Baguley TD, Nairn AC, Lombroso PJ, Ellman JA.

Bioorg Med Chem Lett. 2015 Mar 1;25(5):1044-6. doi: 10.1016/j.bmcl.2015.01.020. Epub 2015 Jan 20.


STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.

Kurup PK, Xu J, Videira RA, Ononenyi C, Baltazar G, Lombroso PJ, Nairn AC.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1202-7. doi: 10.1073/pnas.1417423112. Epub 2015 Jan 12.


Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders.

Karasawa T, Lombroso PJ.

Neurosci Res. 2014 Dec;89:1-9. doi: 10.1016/j.neures.2014.08.018. Epub 2014 Sep 10.


What is the new target inhibiting the progression of Alzheimer's disease.

Zhang L, Yang J, Cao Y.

Neural Regen Res. 2013 Jul 25;8(21):1938-47. doi: 10.3969/j.issn.1673-5374.2013.21.002.


Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer's disease.

Xu J, Chatterjee M, Baguley TD, Brouillette J, Kurup P, Ghosh D, Kanyo J, Zhang Y, Seyb K, Ononenyi C, Foscue E, Anderson GM, Gresack J, Cuny GD, Glicksman MA, Greengard P, Lam TT, Tautz L, Nairn AC, Ellman JA, Lombroso PJ.

PLoS Biol. 2014 Aug 5;12(8):e1001923. doi: 10.1371/journal.pbio.1001923. eCollection 2014 Aug.


Fyn kinase inhibition as a novel therapy for Alzheimer's disease.

Nygaard HB, van Dyck CH, Strittmatter SM.

Alzheimers Res Ther. 2014 Feb 5;6(1):8. doi: 10.1186/alzrt238. eCollection 2014. Review.


From FMRP function to potential therapies for fragile X syndrome.

Sethna F, Moon C, Wang H.

Neurochem Res. 2014 Jun;39(6):1016-31. doi: 10.1007/s11064-013-1229-3. Epub 2013 Dec 18. Review.


The dendritic hypothesis for Alzheimer's disease pathophysiology.

Cochran JN, Hall AM, Roberson ED.

Brain Res Bull. 2014 Apr;103:18-28. doi: 10.1016/j.brainresbull.2013.12.004. Epub 2013 Dec 12. Review.


Substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase.

Baguley TD, Xu HC, Chatterjee M, Nairn AC, Lombroso PJ, Ellman JA.

J Med Chem. 2013 Oct 10;56(19):7636-50. doi: 10.1021/jm401037h. Epub 2013 Oct 1.


Striatal-enriched protein tyrosine phosphatase-STEPs toward understanding chronic stress-induced activation of corticotrophin releasing factor neurons in the rat bed nucleus of the stria terminalis.

Dabrowska J, Hazra R, Guo JD, Li C, Dewitt S, Xu J, Lombroso PJ, Rainnie DG.

Biol Psychiatry. 2013 Dec 1;74(11):817-26. doi: 10.1016/j.biopsych.2013.07.032. Epub 2013 Sep 5.


Cocaine-induced changes of synaptic transmission in the striatum are modulated by adenosine A2A receptors and involve the tyrosine phosphatase STEP.

Chiodi V, Mallozzi C, Ferrante A, Chen JF, Lombroso PJ, Di Stasi AM, Popoli P, Domenici MR.

Neuropsychopharmacology. 2014 Feb;39(3):569-78. doi: 10.1038/npp.2013.229. Epub 2013 Aug 30.


A common STEP in the synaptic pathology of diverse neuropsychiatric disorders.

Johnson MA, Lombroso PJ.

Yale J Biol Med. 2012 Dec;85(4):481-90. Epub 2012 Dec 13. Review.


The tyrosine phosphatase STEP constrains amygdala-dependent memory formation and neuroplasticity.

Olausson P, Venkitaramani DV, Moran TD, Salter MW, Taylor JR, Lombroso PJ.

Neuroscience. 2012 Dec 6;225:1-8. doi: 10.1016/j.neuroscience.2012.07.069. Epub 2012 Aug 9.


Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.

Mihali A, Subramani S, Kaunitz G, Rayport S, Gaisler-Salomon I.

Expert Rev Neurother. 2012 Jul;12(7):785-99. doi: 10.1586/ern.12.60. Review.


Striatal-enriched protein tyrosine phosphatase in Alzheimer's disease.

Xu J, Kurup P, Nairn AC, Lombroso PJ.

Adv Pharmacol. 2012;64:303-25. doi: 10.1016/B978-0-12-394816-8.00009-X. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk